Column Group IV-A, LP, 10% Owner at RAPT Therapeutics, Inc. (RAPT), bought 2,500,000 shares at $10.67 ($26.7M) on 2022-05-10, disclosed to the SEC on 2022-05-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.67 | 41,250 | $440K | 1.7% |
| 2 | $10.67 | 41,250 | $440K | 1.7% |
| 3 | $10.67 | 1,208,750 | $12.9M | 48.3% |
| 4 | $10.67 | 1,208,750 | $12.9M | 48.4% |
| Total | $10.67 avg | 2,500,000 | $26.7M | 100% |
| Filing → |
| RAPT | BUY | 2022-05-25 | $324K | — | Filing → |